The pharmacology of TRP channels
Transient receptor potential (TRP) channels: a clinical perspective
Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics
Transient receptor potential cation channels in visceral sensory pathways
TRP channels in lower urinary tract dysfunction
The TRPA1 channel in migraine mechanism and treatment
TRP channels in the skin
New insights into pharmacological tools to TR(i)P cancer up
Transient receptor potential (TRP) channels in the airway: role in airway disease
Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice
Pharmacological profiling of the TRPV3 channel in recombinant and native assays
Activation and inhibition of transient receptor potential TRPM3-induced gene transcription
Naringenin inhibits the growth of Dictyostelium and MDCK-derived cysts in a TRPP2 (polycystin-2)-dependent manner
C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis